Abstract
New neural models for anorexia nervosa (AN) are emerging as a result of increased research on the neurobiology of AN, and these offer a rationale for the development of new treatment technologies such as neuromodulation. The emergence of such treatment technologies raises new ethical questions; however these have been little discussed for AN. In this article, I take an empirical approach and explore how young women who suffer from AN perceive treatment technologies in light of the concept of authenticity. Interview data showed that participants in this study did not seem to unconditionally adhere to treatment modalities that only imply laborious self-work, such as therapy. The data also showed that they were willing to accept new treatment possibilities such as pharmacological or brain-directed treatment strategies, which they view as having potential instrumental value in coping with certain symptoms of the illness. However, such modalities can pose threats to patients’ authenticity, especially with regard to self-discovery. I argue that, in a context where there is an increased interest in brain-directed treatment strategies for AN, studies should continue to explore the ethical and psychological impact of such treatment technologies on individuals.
Similar content being viewed by others
Notes
When discussing, during the interview, treatment technologies, I asked participants about both medication and brain-based interventions; however the focus was predominantly on the role of brain technologies for treatment. The interview in its wholeness explored how participants viewed the role of brain technologies to diagnose, prevent or treat AN.
References
Abbate-Daga, G., Amianto, F., Delsedime, N., De-Bacco, C., & Fassino, S. (2013). Resistance to treatment and change in anorexia nervosa: A clinical overview. BMC Psychiatry, 13(1), 294.
Bissada, H., Tasca, G. A., Barber, A. M., & Bradwejn, J. (2008). Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 165(10), 1281–1288. doi:10.1176/appi.ajp.2008.07121900.
Borry, P., Schotsmans, P., & Dierickx, K. (2008). The origin and emergence of empirical ethics. In G. Widdershove, J. McMillan, T. Hope, & L. Van Der Scheer (Eds.), Empirical ethics in psychiatry (pp. 38–50). UK: Oxford University Press.
Bracken, P., Thomas, P., Timimi, S., Asen, E., Behr, G., Beuster, C., et al. (2012). Psychiatry beyond the current paradigm. The British Journal of Psychiatry, 201(6), 430–434.
Brenninkmeijer, J. (2013). Neurofeedback as a dance of agency. BioSocieties, 8(2), 144–163.
Bröer, C., & Heerings, M. (2013). Neurobiology in public and private discourse: The case of adults with ADHD. Sociology of Health & Illness, 35(1), 49–65.
Bühren, K., Schwarte, R., Fluck, F., Timmesfeld, N., Krei, M., Egberts, K., et al. (2014). Comorbid psychiatric disorders in female adolescents with first-onset anorexia nervosa. European Eating Disorders Review, 22(1), 39–44. doi:10.1002/erv.2254.
Coman, A., Skårderud, F., & Hofmann, B. M. (2013). A disorder of a vulnerable self: Anorexia nervosa patients’ understanding of disorder and self in the context of fMRI brain scanning. EHPP, 15(2), 120–134.
Dalle Grave, R. (2011). Eating disorders: Progress and challenges. European Journal of Internal Medicine, 22(2), 153–160.
Dalle Grave, R., Calugi, S., Doll, H. A., & Fairburn, C. G. (2013). Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: An alternative to family therapy? Behaviour Research and Therapy, 51(1), R9–r12. doi:10.1016/j.brat.2012.09.008.
Diller, L. H. (2010). The run on ritalin. In J. M. Farah (Ed.), Neuroethics. An introduction with reading (pp. 42–58). Cambridge, MA: The MIT Press.
Halmi, K. (2008). The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients. American Journal of Psychiatry, 165(10), 1227–1228.
Harris, J., & Steele, A. M. (2013). Have we lost our minds? The siren song of reductionism in eating disorder research and theory. Eating Disorders, 22(1), 87–95. doi:10.1080/10640266.2014.857532.
Hay, P. J., Touyz, S., & Sud, R. (2012). Treatment for severe and enduring anorexia nervosa: A review. Australian and New Zealand Journal of Psychiatry, 46(12), 1136–1144. doi:10.1177/0004867412450469.
Hope, T., Tan, J., Stewart, A., & Fitzpatrick, R. (2011). Anorexia nervosa and the language of authenticity. Hastings Center Report, 41(6), 19–29. doi:10.1002/j.1552-146X.2011.tb00153.x.
Kadosh, R. C., Levy, N., O’Shea, J., Shea, N., & Savulescu, J. (2012). The neuroethics of non-invasive brain stimulation. Current Biology, 22(4), R108–R111.
Kaye, W. H. (2009). Eating disorders: hope despite mortal risk. American Journal of Psychiatry, 166(12), 1309–1311.
Keel, P. K., & Brown, T. A. (2010). Update on course and outcome in eating disorders. International Journal of Eating Disorders, 43(3), 195–204.
Kraemer, F. (2011). Me, myself and my brain implant: Deep brain stimulation raises questions of personal authenticity and alienation. Neuroethics, 1–15.
Levy, N. (2011). Enhancing authenticity. Journal of Applied Philosophy, 28(3), 308–318. doi:10.1111/j.1468-5930.2011.00532.x.
Mackenzie, R. (2014). Authenticity versus autonomy in choosing the new me: Beyond IEC and NIEC in DBS. AJOB Neuroscience, 5(1), 51–53.
McClelland, J., Bozhilova, N., Campbell, I., & Schmidt, U. (2013). A systematic review of the effects of neuromodulation on eating and body weight: Evidence from human and animal studies. European Eating Disorders Review, 21(6), 436–455. doi:10.1002/erv.2256.
Meynen, G., & Widdershoven, G. (2014). Why authenticity may be an inherent bioethical DBS concern. AJOB Neuroscience, 5(1), 37–39. doi:10.1080/21507740.2013.863254.
Newson, A. J., & Ashcroft, R. E. (2005). Whither authenticity? The American Journal of Bioethics, 5(3), 53–55. doi:10.1080/15265160591002863.
Pickersgill, M., Cunningham-burley, S., & Martin, P. (2011). Constituting neurologic subjects: Neuroscience, subjectivity and the mundane significance of the brain. Subjectivity, 4, 346–365. doi:10.1057/sub.2011.10.
Singh, I. (2012). When the self is contested ground (4 pp.). The Hastings Center Report.
Singh, I. (2013). Brain talk: Power and negotiation in children’s discourse about self, brain and behaviour. Sociology of Health & Illness, 35(6), 813–827. doi:10.1111/j.1467-9566.2012.01531.x.
Singh, I. (2013). Not robots: Children’s perspectives on authenticity, moral agency and stimulant drug treatments. Journal of Medical Ethics, 39(6), 359–366.
Slotema, C. W., Dirk Blom, J., Hoek, H. W., & Sommer, I. E. C. (2010). Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. Journal of Clinical Psychiatry, 71(7), 873.
Smink, F. R. E., van Hoeken, D., & Hoek, H. W. (2013). Epidemiology, course, and outcome of eating disorders. Current Opinion in Psychiatry, 26(6), 543–548. doi:10.1097/YCO.1090b1013e328365a328324f.
Steinhausen, H. C. (2002). The outcome of anorexia nervosa in the 20th century. American Journal of Psychiatry, 159(8), 1284–1293.
Steinhausen, H. C., Grigoroiu-Serbanescu, M., Boyadjieva, S., Neumarker, K. J., & Winkler, M. C. (2008). Course and predictors of rehospitalization in adolescent anorexia nervosa in a multisite study. International Journal of Eating Disorders, 41(1), 29–36. doi:10.1002/eat.20414.
Strober, M., Freeman, R., & Morrell, W. (1997). The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10ΓÇô15 years in a prospective study. International Journal of Eating Disorders, 22(4), 339–360.
Svenaeus, F. (2009). The ethics of self-change: Becoming oneself by way of antidepressants or psychotherapy? Medicine, Health Care and Philosophy, 12(2), 169–178.
Taylor, C. (1991). The ethics of authenticity (vol. 30). Cambridge: Cambridge Univ Press.
Treasure, J., & Russell, G. (2011). The case for early intervention in anorexia nervosa: Theoretical exploration of maintaining factors. The British Journal of Psychiatry, 199(1), 5–7. doi:10.1192/bjp.bp.110.087585.
Wonderlich, S., Mitchell, J. E., Crosby, R. D., Myers, T. C., Kadlec, K., LaHaise, K., et al. (2012). Minimizing and treating chronicity in the eating disorders: A clinical overview. International Journal of Eating Disorders, 45(4), 467–475. doi:10.1002/eat.20978.
Zipfel, S., Wild, B., Gross, G., Friederich, H. C., Teufel, M., Schellberg, D., et al. (2014). Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): Randomised controlled trial. Lancet, 383(9912), 127–137. doi:10.1016/S0140-6736(13)61746-8.
Acknowledgments
This work has been supported by internal funds from Regional Unit for Eating Disorders, Department for Mental health and addiction, Oslo University Hospital, Ullevål. Thanks to the young women who have participated in this study. I also want to thank Bjørn Hofmann for helpful discussions and comments on earlier drafts of this paper. Thanks also to Ilina Singh for contributing to the development of this project, and to the two anonymous reviewers for valuable comments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coman, A. Emerging Technologies in the Treatment of Anorexia Nervosa and Ethics: Sufferers’ Accounts of Treatment Strategies and Authenticity. Health Care Anal 25, 212–224 (2017). https://doi.org/10.1007/s10728-014-0286-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10728-014-0286-3